AMERICAN RED CROSS TWENTIETH ANNUAL SCIENTIFIC SYMPOSIUM: HEMATOPOIETIC GROWTH FACTORS IN TRANSFUSION MEDICINE. MAY 10-11, 1989, BETHESDA, MD NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AMERICAN RED CROSS TWENTIETH ANNUAL SCIENTIFIC SYMPOSIUM: HEMATOPOIETIC GROWTH FACTORS IN TRANSFUSION MEDICINE. MAY 10-11, 1989, BETHESDA, MD

American Red Cross Twentieth Annual Scientific Symposium: Hematopoietic Growth Factors in Transfusion Medicine. May 10-11, 1989, Bethesda, MD, 1989.. Unique Identifier : AIDSLINE ICDB/90660184
Anonymous; No affiliation given

Abstract: The American Red Cross symposium on Hematopoietic Growth Factors in Transfusion Medicine, held May 10-11, 1989, in Bethesda, MD, consisted of 4 lecture and 2 poster sessions. Abstracts are presented for the following lectures: biology of hematopoiesis and synergy among hematopoietic growth factors; erythropoietin (EPO); human granulocyte-macrophage colony-stimulating factor (GM-CSF); G-CSF; M-CSF; the radioprotective and bone marrow reconstitutive effect of interleukin 1; retrovirally mediated transfer of genes into hematopoietic cells; interleukin 7--a lymphopoietic growth factor; cytokine regulation of megakaryocyte progenitor cells; EPO therapy in autologous blood donors; EPO therapy in AIDS; effect of recombinant human (rh) CSFs on hematopoietic reconstitution following autologous bone marrow transplantation (ABMT); hematopoietic growth factors and human leukemia; hematopoietic growth factor therapy for aplastic anemia; treatment of myelodysplastic syndromes with rhG-CSF--marrow hemopoietic and clinical results; the role of GM-CSF in treatment of AIDS; clinical uses of GM-CSF; effect of recombinant M-CSF on human monocyte-macrophage numbers and candidacidal activity in vitro; effect of transforming growth factor-beta 1 and T lymphocytes on the growth of peripheral blood progenitor cells; rGM-CSF in patients with poor graft function after BMT; tumor cytotoxicity of peripheral blood monocytes from BMT recipients following incubation with recombinant cytokines; depletion of T cells in preparation for allogeneic peripheral blood stem-cell transplantation; EPO-induced maturation of a GM-CSF-dependent human cell line; coordinate induction of c-jun, fibronectin receptor, and hck genes by M-CSF in nonproliferative human monocytes; a sensitive technique to monitor gene transfer and expression in bone marrow stem cells; successful treatment of the anemia of Gaucher's disease with human EPO; and effect of interleukin 3 on survival and proliferation of peripheral blood hematopoietic colony-forming cells in liquid culture.
Keywords: Animal Cell Division/*PHYSIOLOGY Colony-Stimulating Factors/*PHYSIOLOGY Growth Substances/*PHYSIOLOGY Human Leukemia/PHYSIOPATHOLOGY Neoplasms/*PHYSIOPATHOLOGY MONOGRAPHKWDanimalcelldivision/KWDphysiologycolony-stimulatingfactors/KWDphysiologygrowthsubstances/KWDphysiologyhumanleukemia/physiopathologyneoplasms/KWDphysiopathologymonograph
900530
M9051024

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .